668 related articles for article (PubMed ID: 29109786)
1. "One-Pot" Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics.
Luo Y; Wu H; Feng C; Xiao K; Yang X; Liu Q; Lin TY; Zhang H; Walton JH; Ajena Y; Hu Y; Lam KS; Li Y
Theranostics; 2017; 7(16):3901-3914. PubMed ID: 29109786
[TBL] [Abstract][Full Text] [Related]
2. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
[TBL] [Abstract][Full Text] [Related]
3. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy.
Taratula O; Schumann C; Duong T; Taylor KL; Taratula O
Nanoscale; 2015 Mar; 7(9):3888-902. PubMed ID: 25422147
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly of porphyrin-grafted lipid into nanoparticles encapsulating doxorubicin for synergistic chemo-photodynamic therapy and fluorescence imaging.
Hameed S; Bhattarai P; Liang X; Zhang N; Xu Y; Chen M; Dai Z
Theranostics; 2018; 8(19):5501-5518. PubMed ID: 30555560
[TBL] [Abstract][Full Text] [Related]
5. HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy.
Lin TY; Guo W; Long Q; Ma A; Liu Q; Zhang H; Huang Y; Chandrasekaran S; Pan C; Lam KS; Li Y
Theranostics; 2016; 6(9):1324-35. PubMed ID: 27375782
[TBL] [Abstract][Full Text] [Related]
6. Single wavelength light-mediated, synergistic bimodal cancer photoablation and amplified photothermal performance by graphene/gold nanostar/photosensitizer theranostics.
Wu C; Li D; Wang L; Guan X; Tian Y; Yang H; Li S; Liu Y
Acta Biomater; 2017 Apr; 53():631-642. PubMed ID: 28161572
[TBL] [Abstract][Full Text] [Related]
7. A smart and versatile theranostic nanomedicine platform based on nanoporphyrin.
Li Y; Lin TY; Luo Y; Liu Q; Xiao W; Guo W; Lac D; Zhang H; Feng C; Wachsmann-Hogiu S; Walton JH; Cherry SR; Rowland DJ; Kukis D; Pan C; Lam KS
Nat Commun; 2014 Aug; 5():4712. PubMed ID: 25158161
[TBL] [Abstract][Full Text] [Related]
8. A biomimetic theranostic O
Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ
Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939
[TBL] [Abstract][Full Text] [Related]
9. Efficient Uptake of
Yu B; Wei H; He Q; Ferreira CA; Kutyreff CJ; Ni D; Rosenkrans ZT; Cheng L; Yu F; Engle JW; Lan X; Cai W
Angew Chem Int Ed Engl; 2018 Jan; 57(1):218-222. PubMed ID: 29092090
[TBL] [Abstract][Full Text] [Related]
10. From one to all: self-assembled theranostic nanoparticles for tumor-targeted imaging and programmed photoactive therapy.
Li X; Wang X; Zhao C; Shao L; Lu J; Tong Y; Chen L; Cui X; Sun H; Liu J; Li M; Deng X; Wu Y
J Nanobiotechnology; 2019 Feb; 17(1):23. PubMed ID: 30711005
[TBL] [Abstract][Full Text] [Related]
11. Near-Infrared Light Triggered ROS-activated Theranostic Platform based on Ce6-CPT-UCNPs for Simultaneous Fluorescence Imaging and Chemo-Photodynamic Combined Therapy.
Yue C; Zhang C; Alfranca G; Yang Y; Jiang X; Yang Y; Pan F; de la Fuente JM; Cui D
Theranostics; 2016; 6(4):456-69. PubMed ID: 26941840
[TBL] [Abstract][Full Text] [Related]
12. A Laser-Activated Biocompatible Theranostic Nanoagent for Targeted Multimodal Imaging and Photothermal Therapy.
Deng L; Cai X; Sheng D; Yang Y; Strohm EM; Wang Z; Ran H; Wang D; Zheng Y; Li P; Shang T; Ling Y; Wang F; Sun Y
Theranostics; 2017; 7(18):4410-4423. PubMed ID: 29158836
[TBL] [Abstract][Full Text] [Related]
13. Dual-Stimuli Responsive Nanotheranostics for Multimodal Imaging Guided Trimodal Synergistic Therapy.
Fang S; Lin J; Li C; Huang P; Hou W; Zhang C; Liu J; Huang S; Luo Y; Fan W; Cui D; Xu Y; Li Z
Small; 2017 Feb; 13(6):. PubMed ID: 27862953
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
Lian H; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
[TBL] [Abstract][Full Text] [Related]
15. Photochemical /Photocytotoxicity Studies of New Tetrapyrrolic Structures as Potential Candidates for Cancer Theranostics.
Ferreira LFV; Machado IF; Gama A; Socoteanu RP; Boscencu R; Manda G; Calhelha RC; Ferreira ICFR
Curr Drug Discov Technol; 2020; 17(5):661-669. PubMed ID: 30973109
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro.
Li S; Zhang Y; He XW; Li WY; Zhang YK
Talanta; 2020 Mar; 209():120552. PubMed ID: 31892096
[TBL] [Abstract][Full Text] [Related]
17. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
[TBL] [Abstract][Full Text] [Related]
18. All-in-One Theranostic Nanoplatform Based on Hollow MoS
Wang J; Liu L; You Q; Song Y; Sun Q; Wang Y; Cheng Y; Tan F; Li N
Theranostics; 2018; 8(4):955-971. PubMed ID: 29463993
[TBL] [Abstract][Full Text] [Related]
19. Theranostic Nanoparticles with Aggregation-Induced Emission and MRI Contrast Enhancement Characteristics as a Dual-Modal Imaging Platform for Image-Guided Tumor Photodynamic Therapy.
Yang H; He Y; Wang Y; Yang R; Wang N; Zhang LM; Gao M; Jiang X
Int J Nanomedicine; 2020; 15():3023-3038. PubMed ID: 32431499
[TBL] [Abstract][Full Text] [Related]
20. Defect-engineered porphyrinic metal-organic framework nanoparticles for targeted multimodal cancer phototheranostics.
Wang C; Xiong C; Li Z; Hu L; Wei J; Tian J
Chem Commun (Camb); 2021 Apr; 57(33):4035-4038. PubMed ID: 33885676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]